Literature DB >> 27201165

Trends and Key Decision Drivers For Rejecting An Orphan Drug Submission Across Five Different HTA Agencies.

S Mardiguian1, M Stefanidou1, F Sheppard1.   

Abstract

Entities:  

Year:  2014        PMID: 27201165     DOI: 10.1016/j.jval.2014.08.1140

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe.

Authors:  Paweł Kawalec; Anna Sagan; Andrzej Pilc
Journal:  Orphanet J Rare Dis       Date:  2016-09-06       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.